カテゴリ： GlobalData, アメリカ, 企業調査

HTG Molecular Diagnostics Inc (HTGM)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：HTG Molecular Diagnostics Inc (HTGM) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C11414
◆発行会社（調査会社）：GlobalData
◆発行日：2018年11月
◆ページ数：63
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also offers endogenous control array, custom array development, qSelect miRNA gene list, qSelect mRNA gene list, qDiscovery miRNA Version 16, clinical trial support and ingenuity IPA data analysis services, among others. The company serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG is headquartered in Tucson, Arizona, the US.

HTG Molecular Diagnostics Inc (HTGM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
HTG Molecular Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
HTG Molecular Diagnostics Inc, Medical Equipment, Deal Details 12
Venture Financing 12
HTG Molecular Diagnostics Raises USD18 Million in Venture Financing 12
HTG Molecular Diagnostics to Raise USD0.8 Million in Venture Financing 13
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 14
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing 15
Partnerships 16
HTG Molecular Diagnostics and Firalis Enter into Licensing Agreement 16
HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 17
HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 18
HTG Molecular Diagnostics to Enter into Agreement with QIAGEN 19
HTG Molecular Diagnostics Enters into Agreement with Merck 20
HTG Molecular Diagnostics Enters into Research Agreement with Instituto Valenciano de Oncologia 21
HTG Molecular Diagnostics Enters into Research Agreement with Centre Leon Berard 22
HTG Molecular Diagnostics Enters into Co-Development Agreement with Qiagen Manchester 23
HTG Molecular Diagnostics Enters into Agreement with Merck 24
HTG Molecular Diagnostics Amends Research Agreement with Bristol-Myers Squibb 25
HTG Molecular Diagnostics Enters into Distribution Agreement with Gamidor Diagnostics 26
HTG Molecular Diagnostics Enters into Agreement with Thermo Fisher Scientific 27
HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 28
HTG Molecular Diagnostics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 29
HTG Molecular Diagnostics Amends its Agreement with Illumina to Develop IVD Kits for Sequencing Tests 30
HTG Molecular Diagnostics Enters Into Development Agreement With OvaGene Oncology 31
Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 32
HTG Molecular Diagnostics Enters Into Co-Marketing Agreement With John Wayne Cancer Institute 33
HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis 34
Equity Offering 35
HTG Molecular Diagnostics Raises USD40 Million in Public Offering of Shares 35
HTG Molecular Diagnostics Prices IPO for USD50 Million 37
HTG Molecular Diagnostics Inc – Key Competitors 38
HTG Molecular Diagnostics Inc – Key Employees 39
HTG Molecular Diagnostics Inc – Locations And Subsidiaries 40
Head Office 40
Recent Developments 41
Financial Announcements 41
Aug 07, 2018: HTG Molecular Diagnostics reports second quarter 2018 results 41
May 10, 2018: HTG Molecular Diagnostics Reports First Quarter 2018 Results 42
Mar 22, 2018: HTG Molecular Diagnostics Announces Fourth Quarter And Full Year 2017 Results 43
Jan 04, 2018: HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance 44
Nov 07, 2017: HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings 45
Aug 08, 2017: HTG Molecular Diagnostics Reports Second Quarter 2017 Results 46
May 15, 2017: HTG Molecular Diagnostics Reports First Quarter 2017 Results 47
Mar 23, 2017: HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results 48
Corporate Communications 49
Oct 31, 2018: HTG Molecular appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President 49
Aug 16, 2018: HTG Molecular appoints Michelle R. Griffin to its board of directors 50
Apr 16, 2018: HTG Promotes John Lubniewski to President and Chief Operating Officer 51
Mar 07, 2017: HTG Molecular Diagnostics Appoints New Chair of the Board of Directors 52
Legal and Regulatory 53
Sep 18, 2017: HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements 53
Government and Public Interest 54
Jan 10, 2018: University laboratory at Discovery Park is playing key role in early cancer detection research 54
Product News 56
Apr 03, 2018: HTG Announces New Patent for Its Technology Issued in Japan 56
Feb 26, 2018: HTG Announces New Australian Patent for Its Technology 57
Sep 20, 2017: HTG Announces Issuance of Two Method Patents Related to its Technology 58
May 04, 2017: HTG Molecular Diagnostics Introduces HTG EdgeSeq PATH Assay to Launch in Second Quarter 2017 59
Other Significant Developments 60
Sep 27, 2018: HTG Molecular announces extension to precision diagnostic partnership PDP program three for companion diagnostic submission 60
Aug 09, 2018: HTG Molecular announces amendment to second statement of work with QIAGEN Manchester 61
Feb 27, 2017: HTG Molecular Diagnostics Unveils New Direct-Target Sequencing Chemistry to Launch in First Quarter 2017 62
Appendix 63
Methodology 63
About GlobalData 63
Contact Us 63
Disclaimer 63

List of Tables
HTG Molecular Diagnostics Inc, Medical Equipment, Key Facts, 2017 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Deals By Market, 2012 to YTD 2018 9
HTG Molecular Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
HTG Molecular Diagnostics Raises USD18 Million in Venture Financing 12
HTG Molecular Diagnostics to Raise USD0.8 Million in Venture Financing 13
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 14
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing 15
HTG Molecular Diagnostics and Firalis Enter into Licensing Agreement 16
HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 17
HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 18
HTG Molecular Diagnostics to Enter into Agreement with QIAGEN 19
HTG Molecular Diagnostics Enters into Agreement with Merck 20
HTG Molecular Diagnostics Enters into Research Agreement with Instituto Valenciano de Oncologia 21
HTG Molecular Diagnostics Enters into Research Agreement with Centre Leon Berard 22
HTG Molecular Diagnostics Enters into Co-Development Agreement with Qiagen Manchester 23
HTG Molecular Diagnostics Enters into Agreement with Merck 24
HTG Molecular Diagnostics Amends Research Agreement with Bristol-Myers Squibb 25
HTG Molecular Diagnostics Enters into Distribution Agreement with Gamidor Diagnostics 26
HTG Molecular Diagnostics Enters into Agreement with Thermo Fisher Scientific 27
HTG Molecular Diagnostics Enters into Co-Development Agreement with Life Technologies 28
HTG Molecular Diagnostics Enters into Research Agreement with University of Texas MD Anderson Cancer Center 29
HTG Molecular Diagnostics Amends its Agreement with Illumina to Develop IVD Kits for Sequencing Tests 30
HTG Molecular Diagnostics Enters Into Development Agreement With OvaGene Oncology 31
Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 32
HTG Molecular Diagnostics Enters Into Co-Marketing Agreement With John Wayne Cancer Institute 33
HTG Molecular Diagnostics Enters Into Co-Development Agreement With sanofi-aventis 34
HTG Molecular Diagnostics Raises USD40 Million in Public Offering of Shares 35
HTG Molecular Diagnostics Prices IPO for USD50 Million 37
HTG Molecular Diagnostics Inc, Key Competitors 38
HTG Molecular Diagnostics Inc, Key Employees 39

List of Figures
HTG Molecular Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
HTG Molecular Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
HTG Molecular Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
HTG Molecular Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[HTG Molecular Diagnostics Inc (HTGM)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • CMA CGM SA：戦略・SWOT・企業財務分析
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • MISC Bhd (MISC)：石油・ガス：M&Aディール及び事業提携情報
    Summary MISC Bhd (MISC), a subsidiary of Petroliam Nasional Berhad (Petronas), is an international energy shipping and maritime conglomerate. The company is a fully integrated maritime, offshore floating solution, heavy engineering and logistics service provider. Its principal business activities in …
  • MISC Bhd (MISC)：企業の財務・戦略的SWOT分析
    MISC Bhd (MISC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Nova Scotia Power Inc：電力：M&Aディール及び事業提携情報
    Summary Nova Scotia Power Inc (NSP) a subsidiary of Emera Inc is a electric utility that provides electricity distribution services. The utility uses a fuel mix including hydro, tidal, wind, coal, oil, biomass and natural gas to generate electricity. It offers a range of home heating options, includ …
  • Ibersol S.G.P.S., S.A.：企業の戦略・SWOT・財務分析
    Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report Summary Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TAG Oil Ltd (TAO)：企業の財務・戦略的SWOT分析
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas exploration company engaged in the production of crude oil and natural gas across Canada. The company owns and operates oil and gas properties in Surat Basin and Taranaki Basin. The Taranaki Basin is located to the North Island of New Zealand. The comp …
  • GEA Group Aktiengesellschaft：企業の戦略・SWOT・財務分析
    GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • DiaGenic ASA (NEL)-医療機器分野：企業M&A・提携分析
    Summary DiaGenic ASA (DiaGenic) is a medical device company that develops innovative in vitro diagnostic products for early detection of diseases. The company specializes in developing blood-based biomarkers. Its ADtect product is a blood test that helps distinguish mild to moderate range AD from th …
  • Pentagon Federal Credit Union：企業の戦略的SWOT分析
    Pentagon Federal Credit Union - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Tenaga Nasional Berhad：企業の戦略・SWOT・財務情報
    Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Tenaga Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Select Medical Holdings Corporation：企業の戦略・SWOT・財務分析
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Granit AD Skopje：企業の戦略・SWOT・財務情報
    Granit AD Skopje - Strategy, SWOT and Corporate Finance Report Summary Granit AD Skopje - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Keikyu Corporation：企業の戦略・SWOT・財務情報
    Keikyu Corporation - Strategy, SWOT and Corporate Finance Report Summary Keikyu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Active Implants LLC：医療機器：M&Aディール及び事業提携情報
    Summary Active Implants LLC (Active Implants), formerly Active Implants Corp is a medical equipment provider that develops orthopedic equipment. The company develops and commercializes polymer orthopedic implant solutions which include tribofit hip system, tribofit instrumentation equipment, NuSurfa …
  • SYNNEX Corp (SNX)：企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bankinter, S.A.：企業のM&A・事業提携・投資動向
    Bankinter, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bankinter, S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Tishman Realty & Construction Co., Inc.：企業の戦略・SWOT・財務情報
    Tishman Realty & Construction Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Tishman Realty & Construction Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • American Shared Hospital Services (AMS)：企業の財務・戦略的SWOT分析
    Summary American Shared Hospital Services (ASHS) is a healthcare company that offers medical equipment to hospitals and medical centers. The company offers financial and healthcare tech solutions. Its financing solutions comprise feasibility studies and reimbursement analysis, facilities planning an …
  • MEI Pharma Inc (MEIP)-製薬・医療分野：企業M&A・提携分析
    Summary MEI Pharma Inc (MEI), formerly Marshall Edwards Inc is an oncology company that offers clinical development of novel therapies for cancer. The company’s drug candidates comprise pracinostat, an oral HDAC inhibitor which is intended for the treatment of acute myeloid leukemia, myelodysplastic …
  • U.P. Hotels Ltd.：企業の戦略・SWOT・財務情報
    U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary U.P. Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆